Inspiration Healthcare Group PLC Notice of Results and Nomination for AIM Awards (6460Z)
22 Septiembre 2020 - 1:00AM
UK Regulatory
TIDMIHC
RNS Number : 6460Z
Inspiration Healthcare Group PLC
22 September 2020
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Notice of Results and Nomination for AIM Awards
Notice of Results
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company , will announce its unaudited interim results
for the six months ended 31 July 2020 on Tuesday, 6 October
2020.
Neil Campbell, Chief Executive Officer and Jon Ballard, Chief
Financial Officer will deliver an online results presentation open
to all existing and potential investors on Tuesday, 6 October 2020
at 9.30 am UK time. The presentation will also allow for questions
and answers and is expected to end at 11:00 am.
Details of the presentation and the access codes to attend will
be forwarded to existing and potential investors who register their
interest in advance with Alex Walters at Cadogan PR via email to
alex.walters@cadoganpr.com
Investors will be able to submit questions before the event or
at any time during the live presentation.
Nomination for AIM Awards
Inspiration Healthcare has been shortlisted for the Best Use of
AIM Award and the AIM Transaction of the Year Award in the 25(th)
AIM Awards sponsored by BDO in association with the London Stock
Exchange. Voting will take place during November and December and
details of the awards and voting can be seen at -
http://www.aim-awards.co.uk/
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Stephen Keys
Cameron MacRitchie
Cadogan PR Tel: 07771 713608
Alex Walters
alex.walters@cadoganpr.com
About Inspiration Healthcare Group
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in neonatal intensive care &
operating theatres. The Company provides high quality innovative
products to patients around the world which help to improve patient
outcomes and it actively invests in innovative product
opportunities and disruptive technologies.
The Company has key own brand products that can be used within
the first days of life to help premature and sick babies; helping
resuscitation and stabilisation in the first moments of life
through to preventing brain damage and both invasive and
non-invasive respiratory support in terms of capital equipment and
disposable medical devices. Additionally, the Company has its own
range of products for maintaining normothermia pre, during and
post-surgery.
Since September 2019, the Company has acquired Vio Holdings a
designer, manufacturer and supplier of single use respiratory
products and sterile medical consumables and S.L.E., a leading
designer, manufacturer and global provider of neonatal ventilation
products . The Group generates approximately 60% of its revenues
from export markets and around two-thirds of its revenues come from
its own-branded products.
With product availability actively promoted to over 75 countries
through a distribution network, Inspiration Healthcare's success
has been built on continuous innovation, excellent customer service
and an inherent commitment to improving patient outcomes, working
in close collaboration with key opinion leaders across the
globe.
In the UK and Ireland the Group has direct sales teams selling
Group Branded and complementary products from third parties, with
an additional range of home healthcare products. This is supported
by Technical Support for planned preventative maintenance and
emergency assistance.
The Group operates from various sites in the UK for R&D,
Marketing and operations with manufacturing based in Croydon (south
London) and Hailsham (East Sussex). The Group's Head Office is
located in Crawley, a short distance from London's Gatwick Airport.
Further information on Inspiration Healthcare can be found at
www.inspiration-healthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCVFLFLBKLBBBE
(END) Dow Jones Newswires
September 22, 2020 02:00 ET (06:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024